Spire Wealth Management’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-20
Closed -$590 2442
2023
Q4
$590 Buy
+20
New +$398 ﹤0.01% 2342
2022
Q1
Sell
-151
Closed -$1K 2956
2021
Q4
$1K Buy
+151
New +$938 ﹤0.01% 2914
2021
Q2
Sell
-703
Closed -$6K 3047
2021
Q1
$6K Buy
+703
New +$5.74K ﹤0.01% 2604

Other funds holding IMGN

Spire Wealth Management's IMGN Position: Q1 2024 in Review

Spire Wealth Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 20 shares — an estimated $590 sold.

Spire Wealth Management first reported a position in IMGN in Q1 2021 and held it in 3 quarters. The position peaked at $6K in Q1 2021. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Spire Wealth Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Spire Wealth Management sold 20 Immunogen Inc shares in Q1 2024, an estimated $590.
  • Spire Wealth Management first reported a position in Immunogen Inc in Q1 2021 and held it in 3 quarters.
  • Spire Wealth Management's Immunogen Inc position peaked at $6K in Q1 2021.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Spire Wealth Management's 13F filing for Q1 2024, filed 24 Apr 2024.